Glenmark Pharmaceuticals Limited

BSE:532296 Stock Report

Market Cap: ₹293.7b

Glenmark Pharmaceuticals Management

Management criteria checks 1/4

Glenmark Pharmaceuticals' CEO is Glenn Saldanha, appointed in Jan 2001, has a tenure of 23.33 years. total yearly compensation is ₹161.85M, comprised of 80.2% salary and 19.8% bonuses, including company stock and options. directly owns 0.35% of the company’s shares, worth ₹1.04B. The average tenure of the management team and the board of directors is 1.7 years and 12.4 years respectively.

Key information

Glenn Saldanha

Chief executive officer

₹161.9m

Total compensation

CEO salary percentage80.2%
CEO tenure23.3yrs
CEO ownership0.3%
Management average tenure1.7yrs
Board average tenure12.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Glenn Saldanha's remuneration changed compared to Glenmark Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-₹8b

Sep 30 2023n/an/a

-₹1b

Jun 30 2023n/an/a

₹3b

Mar 31 2023₹162m₹130m

₹3b

Dec 31 2022n/an/a

₹9b

Sep 30 2022n/an/a

₹8b

Jun 30 2022n/an/a

₹8b

Mar 31 2022₹158m₹130m

₹9b

Dec 31 2021n/an/a

₹10b

Sep 30 2021n/an/a

₹10b

Jun 30 2021n/an/a

₹10b

Mar 31 2021₹139m₹110m

₹10b

Dec 31 2020n/an/a

₹10b

Sep 30 2020n/an/a

₹9b

Jun 30 2020n/an/a

₹9b

Mar 31 2020₹122m₹91m

₹8b

Dec 31 2019n/an/a

₹7b

Sep 30 2019n/an/a

₹6b

Jun 30 2019n/an/a

₹8b

Mar 31 2019₹157m₹131m

₹9b

Dec 31 2018n/an/a

₹9b

Sep 30 2018n/an/a

₹9b

Jun 30 2018n/an/a

₹7b

Mar 31 2018₹162m₹134m

₹8b

Compensation vs Market: Glenn's total compensation ($USD1.94M) is above average for companies of similar size in the Indian market ($USD566.16K).

Compensation vs Earnings: Glenn's compensation has increased whilst the company is unprofitable.

CEO

Glenn Saldanha (53 yo)

23.3yrs

Tenure

₹161,850,000

Compensation

Mr. Glenn Mario Saldanha has been the Managing Director and Chief Executive Officer of Glenmark Pharmaceuticals Limited since 2000. Mr. Saldanha serves as Chairman at Ichnos Sciences Inc. Mr. Saldanha serv...

Leadership Team

NamePositionTenureCompensationOwnership
Glenn Saldanha
Chairman23.3yrs₹161.85m0.35%
₹ 1.0b
V. Mani
Global CFO & Executive Director6.5yrs₹102.47mno data
Cherylann Pinto
Executive Director of Corporate Services & Executive Directorno data₹45.86m0.27%
₹ 789.3m
Harish Kuber
Company Secretary & Compliance Officer7.3yrs₹5.71mno data
Alind Sharma
President and Chief Human Resources Officer2.3yrsno datano data
Sanjeev Krishan
President and Business Head of North America1.3yrsno datano data
Ulhas Dhuppad
President & Head of Global Pharmaceutical Development1.7yrsno datano data
Indrajit Bose
President & Chief Quality Officerless than a yearno datano data
Brijlal Motwani
President & Global Head of Formulation Operationsless than a yearno datano data
Alok Malik
President & Business Head of India Formulationsless than a yearno datano data
Christoph Stoller
President and Business Head of Europe & Emerging Markets1.3yrsno datano data
Nikhil Amin
President of Innovative Medicines Group & Chief Scientific Officer2.3yrsno datano data

1.7yrs

Average Tenure

56yo

Average Age

Experienced Management: 532296's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Glenn Saldanha
Chairman25.6yrs₹161.85m0.35%
₹ 1.0b
V. Mani
Global CFO & Executive Director6yrs₹102.47mno data
Cherylann Pinto
Executive Director of Corporate Services & Executive Director24.6yrs₹45.86m0.27%
₹ 789.3m
Blanche Saldanha
Non Executive Director18.8yrs₹400.00k0.39%
₹ 1.2b
Rajesh Desai
Non-Executive Independent Director22yrs₹1.70m0.039%
₹ 113.6m
Vijayalakshmi Iyer
Independent Non-Executive Director1.3yrs₹100.00kno data
Dipankar Bhattacharjee
Independent Non-Executive Director3.8yrs₹900.00kno data
Sona Ramasastry
Independent Non-Executive Director5.1yrs₹1.30mno data

12.4yrs

Average Tenure

60yo

Average Age

Experienced Board: 532296's board of directors are seasoned and experienced ( 12.4 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.